COVID is here to stay: countries must decide how to adapt
- PMID: 35013606
- DOI: 10.1038/d41586-022-00057-y
COVID is here to stay: countries must decide how to adapt
Keywords: Epidemiology; Public health; SARS-CoV-2; Vaccines.
Similar articles
-
A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.JAMA. 2022 Jan 18;327(3):215-216. doi: 10.1001/jama.2021.24165. JAMA. 2022. PMID: 34989782 No abstract available.
-
Why scientists are racing to develop more COVID antivirals.Nature. 2022 Jan;601(7894):496. doi: 10.1038/d41586-022-00112-8. Nature. 2022. PMID: 35064230 No abstract available.
-
Antiviral pills could change pandemic's course.Science. 2021 Nov 12;374(6569):799-800. doi: 10.1126/science.acx9605. Epub 2021 Nov 11. Science. 2021. PMID: 34762459 No abstract available.
-
A tale of two drugs: Molnupiravir and Paxlovid.Mutat Res Rev Mutat Res. 2025 Jan-Jun;795:108533. doi: 10.1016/j.mrrev.2025.108533. Epub 2025 Feb 6. Mutat Res Rev Mutat Res. 2025. PMID: 39920989 Review.
-
Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):8019-8022. doi: 10.26355/eurrev_202112_27653. Eur Rev Med Pharmacol Sci. 2021. PMID: 34982466 Review.
Cited by
-
Spatio-temporal distributions of COVID-19 vaccine doses uptake in the Netherlands: a Bayesian ecological modelling analysis.Epidemiol Infect. 2024 Oct 7;152:e119. doi: 10.1017/S0950268824001249. Epidemiol Infect. 2024. PMID: 39370683 Free PMC article.
-
Predicting adherence to COVID-19 preventive measures among South Korean adults aged 40 to 69 Years using the expanded health empowerment model.SSM Popul Health. 2023 Jun;22:101411. doi: 10.1016/j.ssmph.2023.101411. Epub 2023 Apr 24. SSM Popul Health. 2023. PMID: 37123561 Free PMC article.
-
COVID-19 2022 update: transition of the pandemic to the endemic phase.Hum Genomics. 2022 Jun 1;16(1):19. doi: 10.1186/s40246-022-00392-1. Hum Genomics. 2022. PMID: 35650595 Free PMC article. Review.
-
The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines.Vaccines (Basel). 2022 Apr 12;10(4):591. doi: 10.3390/vaccines10040591. Vaccines (Basel). 2022. PMID: 35455340 Free PMC article. Review.
-
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice.Sci Rep. 2023 Mar 21;13(1):4648. doi: 10.1038/s41598-023-31198-3. Sci Rep. 2023. PMID: 36944687 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous